Buchumschlag

Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Peters, Solange (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 8 January 2019
In: Annals of oncology
Year: 2019, Jahrgang: 30, Heft: 2, Pages: 161-165
ISSN:1569-8041
DOI:10.1093/annonc/mdy553
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1093/annonc/mdy553
Volltext
Verfasserangaben:S. Peters, U. Dafni, M. Boyer, D. De Ruysscher, C. Faivre-Finn, E. Felip, P. Garrido, N. Girard, M. Guckenberger, J. Haanen, C. Le Pechoux, F. Mornex, M. Ozsahin, L. Paz-Ares, D. Planchard, D. Raben, S. Ramalingam, M. Reck, E. Smit, R. Stahel, A. Stenzinger, C. Swanton, S. Vallone & M.C. Garassino

MARC

LEADER 00000caa a2200000 c 4500
001 1667380788
003 DE-627
005 20220816171151.0
007 cr uuu---uuuuu
008 190613s2019 xx |||||o 00| ||eng c
024 7 |a 10.1093/annonc/mdy553  |2 doi 
035 |a (DE-627)1667380788 
035 |a (DE-599)KXP1667380788 
035 |a (OCoLC)1341227920 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Peters, Solange  |d 1972-  |e VerfasserIn  |0 (DE-588)113195274X  |0 (DE-627)887311555  |0 (DE-576)488580404  |4 aut 
245 1 0 |a Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)  |c S. Peters, U. Dafni, M. Boyer, D. De Ruysscher, C. Faivre-Finn, E. Felip, P. Garrido, N. Girard, M. Guckenberger, J. Haanen, C. Le Pechoux, F. Mornex, M. Ozsahin, L. Paz-Ares, D. Planchard, D. Raben, S. Ramalingam, M. Reck, E. Smit, R. Stahel, A. Stenzinger, C. Swanton, S. Vallone & M.C. Garassino 
264 1 |c 8 January 2019 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.06.2019 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
773 0 8 |i Enthalten in  |t Annals of oncology  |d Amsterdam [u.a.] : Elsevier, 1990  |g 30(2019), 2, Seite 161-165  |h Online-Ressource  |w (DE-627)320428796  |w (DE-600)2003498-2  |w (DE-576)098134345  |x 1569-8041  |7 nnas  |a Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP) 
773 1 8 |g volume:30  |g year:2019  |g number:2  |g pages:161-165  |g extent:5  |a Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP) 
856 4 0 |u http://dx.doi.org/10.1093/annonc/mdy553  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190613 
993 |a Article 
994 |a 2019 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 21 
999 |a KXP-PPN1667380788  |e 3486789635 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1667380788","id":{"eki":["1667380788"],"doi":["10.1093/annonc/mdy553"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"8 January 2019"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Peters, Solange","family":"Peters","role":"aut","given":"Solange"},{"given":"Albrecht","role":"aut","display":"Stenzinger, Albrecht","family":"Stenzinger"}],"relHost":[{"origin":[{"publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedDisp":"1990-","dateIssuedKey":"1990","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford"}],"id":{"eki":["320428796"],"zdb":["2003498-2"],"issn":["1569-8041"]},"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"320428796","disp":"Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)Annals of oncology","part":{"extent":"5","issue":"2","year":"2019","text":"30(2019), 2, Seite 161-165","volume":"30","pages":"161-165"},"pubHistory":["1.1990 -"],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}]}],"language":["eng"],"title":[{"title":"Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)","title_sort":"Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)"}],"physDesc":[{"extent":"5 S."}],"name":{"displayForm":["S. Peters, U. Dafni, M. Boyer, D. De Ruysscher, C. Faivre-Finn, E. Felip, P. Garrido, N. Girard, M. Guckenberger, J. Haanen, C. Le Pechoux, F. Mornex, M. Ozsahin, L. Paz-Ares, D. Planchard, D. Raben, S. Ramalingam, M. Reck, E. Smit, R. Stahel, A. Stenzinger, C. Swanton, S. Vallone & M.C. Garassino"]},"note":["Gesehen am 13.06.2019"]} 
SRT |a PETERSSOLAPOSITIONOF8201 

Ähnliche Einträge